JPM23: Regeneron reports disappointing sales of powerhouse Eylea, says it’s a ‘blip’ kdunleavy Mon, 01/09/2023 – 14:21 More: JPM23: Regeneron reports disappointing sales of powerhouse Eylea, says it's a 'blip' Source: fierce
read moreJPM23: BMS touts ‘diversified’ portfolio as launches kick into gear and old drugs near patent cliff aliu Mon, 01/09/2023 – 14:20 More: JPM23: BMS touts 'diversified' portfolio as launches kick into gear and old drugs near patent cliff Source: fierce
read moreAgilent to shell out $725M to boost production capacity for biologic APIs jkeenan Mon, 01/09/2023 – 13:20 More: Agilent to shell out 5M to boost production capacity for biologic APIs Source: fierce
read moreBristol Myers Squibb, Pfizer turned away from SCOTUS in high-profile cases kdunleavy Mon, 01/09/2023 – 11:48 More: Bristol Myers Squibb, Pfizer turned away from SCOTUS in high-profile cases Source: fierce
read moreNew financial assistance emerges as UK Government announces imminent discharge fund More: NHS Confederation responds to Prime Minister’s promise of NHS support Source: News
read moreAgreement involves access to global rights of blood pressure lowering therapy baxdrostat More: AstraZeneca makes CinCor Pharma acquisition Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals